Evidence map›Paper›PMID 41997731›Full record

ArticleCold Spring Harbor perspectives in medicine2026

Immunodominant Tuberculosis Antigens Recognized by Human CD4

Deborah A Lewinsohn, Cecilia S Lindestam Arlehamn, Alessandro Sette, David M Lewinsohn

Abstract read
In one paragraph

Article in Cold Spring Harbor perspectives in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Deborah A LewinsohnOregon Health and Science University, Portland, Oregon 97239, USA.
Cecilia S Lindestam ArlehamnCenter for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen 2300, Denmark.
Alessandro SetteCenter for Vaccine Innovation, La Jolla Institute of Immunology, La Jolla, California 92037, USA.
David M LewinsohnOregon Health and Science University, Portland, Oregon 97239, USA lewinsde@ohsu.edu.

Funding

IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB) - SARS-CoV-2 RELATED RESEARCH75N93019C00070 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI URDAHL, KEVIN · 2019 to 2025
$86.6M
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settingsR01AI134246 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI LINDENSTRØM, THOMAS, URDAHL, KEVIN B · 2017 to 2021
$3.3M
Functional Definition of T Cell Receptors Associated with Protection from Pulmonary TB Infection and DiseaseR01AI189603 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAVID M. LEWINSOHN, Deborah A. Lewinsohn · 2025 to 2026
$1.5M
NIAID NIH HHS R01 AI134246NIAID NIH HHS R01 AI189603NIH HHS 75N93019C00070
6 · The paper itself

Abstract

Tuberculosis (TB), caused by infection with

Identifiers

PMID41997731
PMCPMC13552263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.